Bisubstrate Inhibitors of Catechol O‐Methyltransferase (COMT): the Crucial Role of the Ribose Structural Unit for Inhibitor Binding Affinity
暂无分享,去创建一个
F. Diederich | C. Lerner | W. Schweizer | E. Borroni | Ralph Paulini | Christian Trindler | G. Zürcher | R. Jakob‐Roetne | Lukas Brändli
[1] Stephen Neidle,et al. Principles of nucleic acid structure , 2007 .
[2] N. Hayward,et al. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia , 2005, Molecular Psychiatry.
[3] M. Vaudin,et al. Saturation molalities and standard molar enthalpies of solution of 2′-deoxyadenosine · H2O(cr), 2′-deoxycytidine · H2O(cr), 2′-deoxyguanosine · H2O(cr), 2′-deoxyinosine(cr), and 2′-deoxyuridine(cr) in H2O(l) , 2005 .
[4] G. Keating,et al. Tolcapone: a review of its use in the management of Parkinson's disease. , 2005, CNS drugs.
[5] A. Sazci,et al. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women. , 2004, Brain research. Molecular brain research.
[6] F. Diederich,et al. Bisubstrate Inhibitors of the Enzyme Catechol O‐Methyltransferase (COMT): Efficient Inhibition Despite the Lack of a Nitro Group , 2004, Chembiochem : a European journal of chemical biology.
[7] Igor V. Filippov,et al. PROSIT: Pseudo-Rotational Online Service and Interactive Tool, Applied to a Conformational Survey of Nucleosides and Nucleotides , 2004, J. Chem. Inf. Model..
[8] Minmin Yang,et al. Preparation of carbocyclic S-adenosylazamethionine accompanied by a practical synthesis of (-)-aristeromycin. , 2004, The Journal of organic chemistry.
[9] Yuichi Kobayashi,et al. Highly stereoselective synthesis of aristeromycin through dihydroxylation of 4-aryl-1-azido-2-cyclopentenes. , 2004, The Journal of organic chemistry.
[10] Marc C Nicklaus,et al. Experimental and structural evidence that herpes 1 kinase and cellular DNA polymerase(s) discriminate on the basis of sugar pucker. , 2004, Journal of the American Chemical Society.
[11] V. Kostic. Comt inhibition in the treatment of Parkinson's disease: neuroprotection and future perspectives. , 2004, Advances in experimental medicine and biology.
[12] F. Diederich,et al. Bisubstrate inhibitors for the enzyme catechol-O-methyltransferase (COMT): influence of inhibitor preorganisation and linker length between the two substrate moieties on binding affinity. , 2003, Organic & biomolecular chemistry.
[13] C. K. Chu,et al. Practical synthesis of D- and l-2-cyclopentenone and their utility for the synthesis of carbocyclic antiviral nucleosides against orthopox viruses (smallpox, monkeypox, and cowpox virus). , 2003, The Journal of organic chemistry.
[14] M. Vaudin,et al. Saturation molalities and standard molar enthalpies of solution of adenosine(cr), guanosine · 2H2O(cr), inosine(cr), and xanthosine · 2H2O(cr) in H2O(l) , 2003 .
[15] H. Moon,et al. Recent Advances in the Synthesis of Conformationally Locked Nucleosides and Their Success in Probing the Critical Question of Conformational Preferences by Their Biological Targets , 2003, Nucleosides, nucleotides & nucleic acids.
[16] A. Charette,et al. (2S,3S)‐(+)‐(3‐Phenylcyclopropyl)Methanol , 2003 .
[17] F. Diederich,et al. Bisubstrate Inhibitors for the Enzyme Catechol O-Methyltransferase (COMT): Dramatic Effects of Ribose Modifications on Binding Affinity and Binding Mode , 2003 .
[18] Juan B Rodriguez,et al. New progresses in the enantioselective synthesis and biological properties of carbocyclic nucleosides. , 2003, Mini reviews in medicinal chemistry.
[19] P. Soares-da-Silva,et al. Kinetic inhibitory profile of BIA 3-202, a novel fast tight-binding, reversible and competitive catechol-O-methyltransferase inhibitor. , 2003, European journal of pharmacology.
[20] J. Beckmann,et al. A highly significant association between a COMT haplotype and schizophrenia. , 2002, American journal of human genetics.
[21] M. A. Carrondo,et al. Kinetics and crystal structure of catechol-o-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application. , 2002, Molecular pharmacology.
[22] C. Stefanis,et al. Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity allele , 2002, Molecular Psychiatry.
[23] R. Mach,et al. Synthesis of 2-(2,3-dimethoxyphenyl)-4-(aminomethyl)imidazole analogues and their binding affinities for dopamine D(2) and D(3) receptors. , 2001, Bioorganic & medicinal chemistry.
[24] Daniel R. Weinberger,et al. Prefrontal neurons and the genetics of schizophrenia , 2001, Biological Psychiatry.
[25] F. Diederich,et al. X-ray Crystal Structure of a Bisubstrate Inhibitor Bound to the Enzyme Catechol-O-methyltransferase: A Dramatic Effect of Inhibitor Preorganization on Binding Affinity. , 2001, Angewandte Chemie.
[26] S. Takamatsu,et al. Radical deoxygenation and dehalogenation of nucleoside derivatives with hypophosphorous acid and dialkyl phosphites , 2001 .
[27] J. McCarthy. COMT and schizophrenia: biology meets genetics , 2001 .
[28] K. Kato,et al. Sugar-modified nucleosides in past 10 years, a review. , 2001, Current medicinal chemistry.
[29] F. Diederich,et al. Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT). , 2000, Chemistry.
[30] Xue-feng Zhu,et al. The Latest Progress in the Synthesis of Carbocyclic Nucleosides , 2000, Nucleosides, nucleotides & nucleic acids.
[31] M. Nicklaus,et al. Adenosine deaminase prefers a distinct sugar ring conformation for binding and catalysis: kinetic and structural studies. , 2000, Biochemistry.
[32] P. Männistö,et al. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. , 1999, Pharmacological reviews.
[33] M. Fava,et al. Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder. , 1999, Journal of clinical psychopharmacology.
[34] C. Spencer,et al. Entacapone. A review of its use in Parkinson's disease. , 1999, Drugs.
[35] D. Crich,et al. One Pot Selective 5′-Oxidation/Olefination of 2′-Deoxynucleosides , 1999 .
[36] H. Juteau,et al. Enantioselective Cyclopropanation of Allylic Alcohols with Dioxaborolane Ligands: Scope and Synthetic Applications , 1998 .
[37] M. Crimmins. New developments in the enantioselective synthesis of cyclopentyl carbocyclic nucleosides , 1998 .
[38] A. Matsuda,et al. NMR conformation of (-)-beta-D-aristeromycin and its 2 '-deoxy and 3 '-deoxy counterparts in aqueous solution , 1998 .
[39] R. Borchardt,et al. Synthesis of homologated halovinyl derivatives from aristeromycin and their inhibition of human placental S-adenosyl-L-homocysteine hydrolase. , 1998, Nucleosides & nucleotides.
[40] G. Roth,et al. A concise synthesis of 1-(3-hydroxymethyl-4,5-dihydroxyphenyl)-2-tert-butylamino-ethanol (5-hydroxyalbuterol) , 1996 .
[41] F. Seela,et al. Conformational Analysis of 3′-Deoxy-β-D-Ribonucleosides Using 1D-noe Difference Spectroscopy , 1996 .
[42] J. Plavec,et al. How do the energetics of the stereoelectronic gauche and anomeric effects modulate the conformation of nucleos(t)ides? , 1996 .
[43] Paul R. Gerber,et al. MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry , 1995, J. Comput. Aided Mol. Des..
[44] L. Agrofoglio,et al. Synthesis of carbocyclic nucleosides , 1995 .
[45] Anders Liljas,et al. Crystal structure of catechol O-methyltransferase , 1994, Nature.
[46] B. Froehler,et al. Triple-helix formation by oligodeoxynucleotides containing the carbocyclic analogs of thymidine and 5-methyl-2'-deoxycytidine , 1992 .
[47] A. D. Borthwick,et al. Synthesis of Chiral Carbocyclic Nucleosides , 1992 .
[48] H. Kuzuhara,et al. General method for the synthesis of 2′-azido-2′,3′-dideoxynucleosides by the use of [1,2]-hydride shift and β-elimination reactions , 1992 .
[49] G. Thomas,et al. Solution conformations of nucleoside analogues exhibiting antiviral activity against human immunodeficiency virus , 1991 .
[50] Janos Borgulya,et al. Catechol-O-methyltransferase-inhibiting pyrocatechol derivatives: synthesis and structure-activity studies , 1989 .
[51] Chuo,et al. Correlation between preferred sugar ring conformation and activity of nucleoside analogues against human immunodeficiency virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[52] H. Kuzuhara,et al. Facile transformation of β-D-ribofuranosyl purines and pyrimidines into their respective 3′-deoxy-threo-pentofuranosyl nucleosides , 1989 .
[53] Keiji,et al. Reductive Cleavage of the O-C(8) Bond in 5'-O, 8-Cycloadenosines. : Intramolecular Protection of the 8-Position and the 5'-Hydroxy Group in Adenosines. , 1988 .
[54] P. Molière,et al. Regioselective O-p-toluenesulfonylation of nucleosides under solid/liquid phase-transfer conditions , 1987 .
[55] J. Kelley,et al. Synthesis and base-mediated dehydrochlorination of 6-chloro-7,8-dihydro-9-(4-methylbenzyl)-2-(trifluormethyl)purine , 1986 .
[56] Narula Ss,et al. Conformational studies on adenosine and its analogs by proton magnetic resonance. , 1985 .
[57] T. Sato. Structure of 2'-deoxyadenosine, C10H13N5O3 , 1984 .
[58] F. Hansske,et al. Nucleic acid related compounds. 45. A deoxygenative [1,2]-hydride shift rearrangement converting cyclic cis-diol monotosylates to inverted secondary alcohols , 1983 .
[59] D. Norman,et al. A Convenient Preparation of 3′-Deoxyadenosine , 1983 .
[60] M. Prada,et al. Rapid and Sensitive Single‐Step Radiochemical Assay for Catechol‐O‐Methyltransferase , 1982, Journal of neurochemistry.
[61] H. R. Wilson,et al. The structure of cordycepin , 1980 .
[62] Cornelis Altona,et al. Empirical Correlations Between Conformational Parameters in β‐D‐Furanoside Fragments Derived from a Statistical Survey of Crystal Structures of Nucleic Acid Constituents Full Description of Nucleoside Molecular Geometries in Terms of Four Parameters , 1980 .
[63] J. Knowles,et al. Propane-1,3-dithiol: A selective reagent for the efficient reduction of alkyl and aryl azides to amines , 1979 .
[64] E. Westhof,et al. Proton magnetic resonance studies of 2'-,3'-, and 5'-deoxyadenosine conformations in solution. , 1977, Nucleic acids research.
[65] R. Borchardt,et al. Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 6. Structural modifications of S-adenosylmethionine. , 1976, Journal of medicinal chemistry.
[66] R. Borchardt,et al. S-Aristeromycinyl-L-homocysteine, a potent inhibitor of S-adenosylmethionine-dependent transmethylations. , 1976, Journal of medicinal chemistry.
[67] C. Marsden,et al. Catechol-O-methyl transferase: pharmacological aspects and physiological role. , 1975, Pharmacological reviews.
[68] R. Borchardt,et al. Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 3. Modifications of the sugar portion of S-adenosylhomocysteine. , 1975, Journal of medicinal chemistry.
[69] R. E. Marsh,et al. The Crystal Structure of Adenosine , 1972 .
[70] P. Molinoff,et al. Biochemistry of catecholamines. , 1971, Annual review of biochemistry.
[71] M. Shibata,et al. Streptomyces citricolor nov. sp. and a new antibiotic, aristeromycin. , 1968, The Journal of antibiotics.
[72] A. Schönberg,et al. Organische Schwefelverbindungen, LIV. Synthesen von Thiocarbonylverbindungen durch Einwirkung von Kaliumxanthogenat oder Thioharnstoffen auf gem. Dichloride , 1968 .
[73] K. Kamiya,et al. The Structure of Aristeromycin , 1972 .
[74] D. G. Watson,et al. The crystal structure of deoxyadenosine monohydrate. , 1965, Acta crystallographica.
[75] J. Axelrod,et al. Enzymatic O-methylation of epinephrine and other catechols. , 1958, The Journal of biological chemistry.